Contact: Joleen Rau
Senior Director, Marketing & Communications
Cellular Dynamics International, Inc.
(608) 310-5142
jrau@cellulardynamics.com
Robert E. Flamm, Ph.D.
Russo Partners LLC
212-845-4226
robert.flamm@russopartnersllc.com
Investor Relations
Gitanjali Jain Ogawa
The Trout Group, LLC
646 378-2949
gogawa@troutgroup.com
MADISON, Wis., Sept. 30, 2013 (GLOBE NEWSWIRE) — Cellular Dynamics
International (Nasdaq:ICEL), a developer and manufacturer of fully
functioning human cells in industrial quantities to precise
specifications, will be added to the U.S. small-cap Russell 2000(R)
Index on September 30 when Russell Investments reconstitutes its
comprehensive family of global indexes. Membership in the Russell 2000,
which will remain in place until the Index is rebalanced in June 2014,
is based on membership in the broad-market Russell 3000(R) Index. The
stock also will be added systematically to the appropriate growth and
value indexes. The Russell indices are often used by equity fund
managers as benchmarks to measure relative performance of their funds.
Robert Palay, chief executive officer of CDI, commented, “We are
pleased to be added to the Russell 2000 Index, particularly so soon
after our Initial Public Offering in July. We welcome the distinction
and believe our inclusion will increase Cellular Dynamics’ visibility
in the investment community and generate further interest in our
stock.”
Russell indexes are widely used by investment managers and
institutional investors for index funds and as benchmarks for both
passive and active investment strategies. Approximately $4.1 trillion
in assets currently are benchmarked to them. Russell calculates more
than 80,000 benchmarks daily covering approximately 98 percent of the
investable market globally, more than 80 countries and 10,000
securities. These investment tools originated from Russell’s
multi-manager investment business in the early 1980s when the company
saw the need for a more objective, market-driven set of benchmarks to
evaluate outside investment managers. Real-time market analysis on the
Russell 2000 and other Russell Indexes is available at
http://www.russell.com/indexes/data/US_Equity/Russell_US_Index_returns.
asp.
About Russell:
Russell Investments (Russell) is a global asset manager and one of only
a few firms that offers actively managed multi-asset portfolios and
services that include advice, investments and implementation. Russell
stands with institutional investors, financial advisors and individuals
working with their advisors–using the firm’s core capabilities that
extend across capital market insights, manager research, portfolio
construction, portfolio implementation and indexes to help each achieve
their desired investment outcomes.
Russell has more than $173 billion in assets under management (as of
3/31/2013) and works with over 2,500 institutional clients, independent
distribution partners and individual investors globally. As a
consultant to some of the largest pools of capital in the world,
Russell has $2.6 trillion in assets under advisement (as of
12/31/2012). It has four decades of experience researching and
selecting investment managers and meets annually with more than 2,200
managers around the world. Russell traded more than $1.4 trillion in
2012 through its implementation services business.
About Cellular Dynamics International, Inc.
Cellular Dynamics International, Inc. (CDI) is a leading developer of
induced pluripotent stem cell technologies for in vitro drug
development, stem cell banking and in vivo cellular therapeutic
research. CDI harnesses its unique manufacturing technology to produce
differentiated tissue cells in industrial quality, quantity and purity
from any individual’s induced pluripotent stem cell line created from a
standard blood draw. CDI was founded in 2004 by Dr. James Thomson, a
pioneer in human pluripotent stem cell research at the University of
Wisconsin-Madison. CDI’s facilities are located in Madison, Wisconsin,
with a second facility in Novato, California. See
www.cellulardynamics.com.Follow us on Twitter @CellDynamics or
www.twitter.com/celldynamics
Forward-looking Statements
To the extent that statements contained in this press release are not
descriptions of historical facts regarding Cellular Dynamics
International, Inc., including statements regarding the investment
community’s interest in our stock, they are forward-looking statements
reflecting the current beliefs and expectations of management made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Words such as “may,” “will,” “believe,”
“expect,” “anticipate,” “estimate,” “intend,” and similar expressions
(as well as other words or expressions referencing future events,
conditions or circumstances) are intended to identify forward-looking
statements. Forward-looking statements in this release involve
substantial risks and uncertainties that could cause our product
development efforts, actual results, performance or achievements to
differ materially from those expressed or implied by the
forward-looking statements. Cellular Dynamics undertakes no obligation
to update or revise any forward-looking statements. For a further
description of the risks and uncertainties that could cause actual
results to differ from those expressed in these forward-looking
statements, as well as risks relating to the business of the Company in
general, see Cellular Dynamic’s Prospectus filed with the Securities
and Exchange Commission on July 26, 2013.
